AstraZeneca
Moderna vax approval continues apace
“Critical laboratory materials” arrive in country as hopes build for availability of new vax alternative With the wider vaccine focus on the paucity of Pfizer’s Comirnaty and the abundance of …
Bringing the schedule forward
More pharmacies to be ‘brought into play’ earlier than expected to provide AZ vaccine, General heading the Vax program predicts Australia is now a “path to bring pharmacies into play …
Know your obligations
PDL issues guidance on administering the AstraZeneca COVID-19 vaccine to patients below 60 years Pharmaceutical Defence Limited (PDL) says its professional officers have received several calls relating to the administration …
Vaccine woes
Use of Astra Zeneca’s COVID vaccine to be restricted in under 50’s due to rare clotting event, with GP’s advised to cancel bookings The issues currently impacting Australia’s COVID-19 vaccine …
Vaccine questions confronted
Minister and health officials talk up Australia’s vaccine program as first clotting case emerges and questions over speed continue Health Minister Greg Hunt and leading medical officials have moved to …
Moving forward
TGA opens the first door on the COVID vaccine registration pathway for AZ option The Therapeutic Goods Administration (TGA) has granted a provisional determination to AstraZeneca for its COVID-19 Vaccine, …
A win for full-line wholesalers
Pharmaceutical manufacturer ditches direct distribution model for CSO wholesalers in move driven by pharmacist feedback AstraZeneca has announced it will exit its exclusive-direct distribution arrangements and return supply of its …
Community pharmacy concerns over direct supply
Guild says it is “actively lobbying” the Health Minister, arguing that exclusive direct supply increases complexity and cost for pharmacies Following last week’s revelation that AstraZeneca will be exclusively distributing …
Distribution dust-up
Calls for supply chain guarantees as another pharma company decides to explore direct distribution to pharmacy The National Pharmaceutical Services Association (NPSA) is calling for the Federal Government to ensure …
Potential new drug to treat severe, uncontrolled asthma
Trial results suggest treatment could be used as an add-on therapy for severely asthmatic patients Two phase III, double-blind, randomised controlled trials including more than 2500 participants looked at the safety …